| Catalog | Product Name | EC No. | CAS No. | Source | Price |
|---|---|---|---|---|---|
| DIA-570 | KOD DNA Polymerase (without dNTP) | Inquiry | |||
| DIA-571 | Lysozyme | Inquiry | |||
| DIA-572 | Micrococcal Nuclease | 9026-81-7 | Inquiry | ||
| DIA-573 | rTEV Protease | Inquiry | |||
| DIA-574 | Shrimp Alkaline Phosphatase (SAP) | Inquiry | |||
| DIA-575 | SUMO Protease (Lyophilized Powder) | Inquiry | |||
| DIA-576 | T4 RNA Ligase 1 | Inquiry | |||
| DIA-577 | T7 RNA Polymerase | Inquiry | |||
| DIA-578 | Taq DNA Ligase | Inquiry |
Polymerase chain reaction and real-time quantitative PCR depend on coordinated interactions among a thermostable DNA polymerase, primers, nucleotides, magnesium, buffer components, and the selected fluorescence chemistry. Conventional PCR is generally evaluated by endpoint product analysis, whereas qPCR records fluorescence during amplification and requires control of amplification efficiency, baseline behavior, and nonspecific signal.
Hot-start polymerases can reduce extension from misprimed structures formed during setup. Standard Taq-type enzymes are suitable for many routine assays, while specialized polymerases and premixes may be selected for multiplexing, inhibitor tolerance, fast cycling, high specificity, or dry-reagent development. A premix reduces manual additions, but its performance still depends on the complete assay design.
Creative Enzymes supplies Taq DNA polymerases, hot-start and multiplex-oriented polymerases, glycerol-free and lyophilization-oriented formats, dNTPs, dUTP, UDG, and related molecular diagnostic reagents. We also support PCR and qPCR enzyme and premix development for application-specific systems.
PCR uses repeated denaturation, primer annealing, and extension cycles to generate an amplicon. qPCR adds a fluorescence measurement, commonly through an intercalating dye or sequence-specific probe. Dye assays can report any sufficiently abundant double-stranded product, whereas probe assays add sequence-dependent detection but require compatible probe chemistry and optical channels. Neither format eliminates the need for primer specificity and appropriate controls.
Polymerase activity measured in a supplier assay does not by itself predict diagnostic performance. Hot-start mechanism, extension rate, 5′ nuclease activity where probe hydrolysis is required, fidelity, resistance to sample-derived inhibitors, and compatibility with dUTP/UDG carryover control may all affect the final assay. Magnesium, salts, enhancers, stabilizers, passive dyes, and preservative systems can shift specificity and efficiency.
Product selection should begin with the complete reaction and workflow rather than an isolated activity value. The following components represent practical roles that may be evaluated for PCR/qPCR enzymes and master mixes development.
| Enzyme or Reagent | Role in the Workflow | Representative Product or Support | Selection Considerations |
|---|---|---|---|
| Standard Taq DNA polymerase | Routine endpoint PCR and selected qPCR workflows | Taq DNA Polymerase | Amplicon length, extension rate, template quality, buffer and magnesium |
| Glycerol-free polymerase | Dry-reagent and formulation development | Taq DNA Polymerase (Glycerol-free) | Concentration, reconstitution, drying recovery and storage stability |
| Hot-start polymerase | Improved setup-time control and specificity | HotStart Taq DNA Polymerase | Activation profile, cycling program, residual low-temperature activity |
| Multiplex polymerase | Simultaneous amplification of multiple targets | Taq Pro multiplex options | Primer competition, target balance, fluorescence channels and low-copy recovery |
| Nucleotide system | Substrates for DNA synthesis and optional carryover control | dNTP products and dUTP | Purity, concentration, dUTP fraction, freeze-thaw history |
| Custom master mix | Configured enzyme, buffer and reagent system | PCR/qPCR premix development | Sample, target, chemistry, instrument, controls and stability target |
Routine endpoint PCR, singleplex qPCR, multiplex qPCR, genotyping, and direct amplification place different demands on a polymerase. For a short, purified DNA target, a standard Taq-type enzyme may provide adequate yield. A multiplex assay instead requires controlled competition among primer pairs and consistent extension across targets. Direct amplification adds inhibitors and variable target release, while probe-based qPCR may require suitable 5′ nuclease activity. The enzyme should therefore be selected against the intended target panel and specimen process, not only a purified control template.
Hot-start behavior is especially relevant when reactions are assembled at room temperature or contain many primers. The activation step must suppress low-temperature extension without consuming too much of the thermal program. A very stringent activation profile may improve specificity but can reduce available activity in unusually short protocols. Glycerol-free products may simplify dry-formulation development, although removal of glycerol changes the stabilizing environment and requires independent assessment of liquid handling, freeze-thaw tolerance, drying recovery, and reconstitution.
Key factors to define and verify include:
These factors should be studied together because improving one response can shift background, recovery, reaction time, or compatibility elsewhere in the workflow. Final acceptance criteria should reflect the intended reagent configuration and sample process.
qPCR evaluation should include more than the appearance of an amplification curve. A dilution series can characterize efficiency, linearity, and usable range, but those values depend on threshold placement, template preparation, and replicate design. Near the limit of detection, replicate positivity and concentration-specific detection rates are more informative than a single threshold-cycle value. No-template controls should remain negative within the predefined valid reading window, and late nonspecific fluorescence should not be reclassified after reviewing outcomes.
For multiplex assays, each target should first be characterized alone and then in the complete panel. A high-concentration target can consume primers, nucleotides, polymerase capacity, or optical range and thereby suppress a weak target. Fluorescence compensation cannot correct biochemical competition. Inclusivity, near-neighbor exclusivity, cross-reactivity, interference, carryover control, and instrument-to-instrument studies should use the final primer, probe, enzyme, and buffer composition.
Key factors to define and verify include:
These factors should be studied together because improving one response can shift background, recovery, reaction time, or compatibility elsewhere in the workflow. Final acceptance criteria should reflect the intended reagent configuration and sample process.
A master mix combines enzyme, nucleotides, magnesium, salts, stabilizers, and optional components such as UDG, passive dye, or enhancers. Concentrated mixes must remain homogeneous and pipettable throughout storage. Changes in ionic strength or contributed enzyme-storage buffer can alter primer annealing and probe fluorescence. Preservatives and surfactants should be evaluated for both biochemical compatibility and the materials used in tubes, cartridges, or automated liquid-handling systems.
Scale-up should preserve order of addition, mixing, hold times, filtration strategy where applicable, filling accuracy, and cold-chain exposure. Release testing should include functional amplification with representative templates rather than enzyme concentration alone. Accelerated studies can identify degradation pathways, but shelf life should be assigned from appropriately designed real-time data. If the intended product will be dried, the liquid baseline and the drying process should be controlled as separate development stages.
Key factors to define and verify include:
These factors should be studied together because improving one response can shift background, recovery, reaction time, or compatibility elsewhere in the workflow. Final acceptance criteria should reflect the intended reagent configuration and sample process.
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Evaluation should include:
Acceptance criteria should be tied to the intended sample-to-result workflow and verified using appropriate controls.
Potential risks to evaluate include:
Relevant challenge levels and acceptance criteria depend on the intended use, sample matrix, reaction format, instrument, and decision threshold. Performance should be established with the final formulation rather than inferred from individual-component specifications.
Troubleshooting PCR/qPCR enzymes and master mixes is most efficient when the workflow is divided into sample preparation, enzyme reaction, signal generation, and result interpretation. A positive control and a negative control are necessary, but they may not identify which module failed. Orthogonal measurements and module-specific controls should be selected before changing multiple reagents at once.
| Observation | Possible Causes | Focused Checks |
|---|---|---|
| Weak or delayed amplification | Low active polymerase, inhibition, poor primer annealing, or target loss | Compare a purified-template control, dilution for inhibition, enzyme titration, and amplicon-specific controls |
| Late signal in negative controls | Primer dimers, off-target amplification, or carryover | Review product identity, shorten the valid read window, and challenge the UDG/dUTP process |
| One multiplex target is suppressed | Primer competition, unequal efficiency, or fluorescence imbalance | Test each assay singly, vary primer/probe concentrations, and titrate the dominant target |
| Efficiency changes between lots | Raw-material or mixing differences | Compare retained lots using the same template panel, instrument, thresholds, and handling |
A single successful repeat does not confirm the cause of a failure. Once a likely factor is identified, the proposed correction should be challenged across target levels, representative matrices, reagent lots, instruments or devices, operators, and relevant environmental conditions. The final procedure should define valid controls, acceptance criteria, and actions for invalid runs.
Need Help Selecting PCR/qPCR Enzymes or a Master Mix?
Share your target, sample type, workflow, detection chemistry, instrument, desired reagent format, current formulation, performance goals, and expected scale with our technical team.
Request Product Selection Support
Q1. What should be defined before product selection?
Q2. Can supplier activity units be compared directly?
Q3. Are individual enzymes available separately?
Q4. Does a premix remove the need for validation?
Q5. Can Creative Enzymes support formulation development?
Q6. What information should be included in an inquiry?
